FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...

Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...

Moving labour out of low-productivity agriculture and into higher-productivity manufacturing is crucial for economic transformation in Africa. Expanding manufacturing production and exports, and ...

Are you a new Canadian investor and looking for a place to start? Here's an easy five-stock portfolio for a mix of growth, ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...